Inventor · disambiguated record
Steven M. Albelda
Also filed as: ALBELDA STEVEN · ALBELDA STEVEN M
10 granted patents·24 pending applications·80 citations·filing 2005–2024
87Inventor score
Top patents by PatentIndex Score
34 records- 0195US9365641B2Compositions and methods for targeting stromal cells for the treatment of cancerUNIV PENNSYLVANIA·Filed 2013·Granted Jun 14, 2016·54 cites·26 claims
- 0286US11786551B2Methods for treating heart disease via redirected T cell immunotherapiesUNIV PENNSYLVANIA·Filed 2018·Granted Oct 17, 2023·4 cites·11 claims
- 0386US9937205B2Inhibition of diacylglycerol kinase to augment adoptive T cell transferUNIV PENNSYLVANIA·Filed 2013·Granted Apr 10, 2018·7 cites·14 claims
- 0482US7514219B2Method for distinguishing between head and neck squamous cell carcinoma and lung squamous cell carcinomaWISTAR INST·Filed 2006·Granted Apr 7, 2009·4 cites·4 claims
- 0579US8476420B2Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cellsSHOWE MICHAEL·Filed 2008·Granted Jul 2, 2013·11 cites·7 claims
- 0679US2024307445A1Inhibition of Diacylglycerol Kinase to Augment Adoptive T cell TransferUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 0779US2023416408A1Compositions and Methods for Targeting Stromal Cells for the Treatment of CancerUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 0876US2025368750A1Shp inhibitor compositions and uses for chimeric antigen receptor therapyNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0974US2022249490A1Gene therapy for mesotheliomaUNIV PENNSYLVANIA·Filed 2021·Application pending·0 cites
- 1073US11718685B2Compositions and methods for targeting stromal cells for the treatment of cancerUNIV PENNSYLVANIA·Filed 2019·Granted Aug 8, 2023·0 cites·8 claims
- 1171US11931380B2Inhibition of diacylglycerol kinase to augment adoptive T cell transferUNIV PENNSYLVANIA·Filed 2021·Granted Mar 19, 2024·0 cites·4 claims
- 1271US2019314378A1Gene Therapy For MesotheliomaUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 1370US2024293452A1Compositions and methods of enhancing anti-tumor response using hybrid neutrophilsUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 1468US2024016848A1Compositions and Methods for Treating Heart Disease via Redirected T Cell ImmunotherapiesUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 1567US2020191791A1Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cellsWISTAR INST·Filed 2019·Application pending·0 cites
- 1662US11925662B2Compositions and methods of enhancing anti-tumor response using hybrid neutrophilsUNIV PENNSYLVANIA·Filed 2020·Granted Mar 12, 2024·0 cites·16 claims
- 1761US2019008898A1Inhibition of Diacylglycerol Kinase to Augment Adoptive T cell TransferUNIV PENNSYLVANIA·Filed 2018·Application pending·0 cites
- 1860US2019167690A1Immuno-Gene Combination TherapyUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 1958US10329355B2Compositions and methods for targeting stromal cells for the treatment of cancerUNIV PENNSYLVANIA·Filed 2016·Granted Jun 25, 2019·0 cites·9 claims
- 2056US2016282348A1Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cellsWISTAR INST·Filed 2016·Application pending·0 cites
- 2155US2014005065A1Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cellsUNIV PENNSYLVANIA·Filed 2013·Application pending·0 cites
- 2254US2007292394A1Treatment of non-neuronal cancer using hsv-1 variantsCRUSADE LAB LTD·Filed 2007·Application pending·0 cites
- 2353US2021106674A1Gene Therapy For MesotheliomaUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 2452US2005226850A1Treatment of non-neuronal cancer using HSV-1 variantsUNIV PENNSYLVANIA·Filed 2005·Application pending·0 cites
- 2551US2011195053A1Treatment of Non-Neuronal Cancer using HSV-1 VariantsUNIV PENNSYLVANIA·Filed 2011·Application pending·0 cites
- 2651US2011262466A1Compositions containing thrombomodulin domains and uses thereofUNIV PENNSYLVANIA·Filed 2009·Application pending·0 cites
- 2750US2018250336A1Compositions and methods of enhancing anti-tumor response using hybrid neutrophilsUNIV PENNSYLVANIA·Filed 2016·Application pending·0 cites
- 2850US2020390811A1Compositions to disrupt protein kinase a anchoring and uses thereofUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 2948US2016017286A1Ikaros inhibition to augment adoptive t cell transferUNIV PENNSYLVANIA·Filed 2014·Application pending·0 cites
- 3048US2020048359A1Shp inhibitor compositions and uses for chimeric antigen receptor therapyNOVARTIS AG·Filed 2018·Application pending·0 cites
- 3146US12128069B2Treatment of cancer using chimeric antigen receptor and protein kinase a blockerNOVARTIS AG·Filed 2016·Granted Oct 29, 2024·0 cites·46 claims
- 3241US2013323283A1Compositions and methods for treating foxp3+ treg related diseasesHANCOCK WAYNE W·Filed 2011·Application pending·0 cites
- 3341US2018092968A1Compositions to disrupt protein kinase a anchoring and uses thereofUNIV PENNSYLVANIA·Filed 2016·Application pending·0 cites
- 3436US2014295426A1Methods for Diagnosing Cancer by Characterization of Tumor Cells Associated with Pleural or Serous FluidsALBELDA STEVEN M·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven M. Albelda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →